Chemotherapy and pregnancy
Most people who have had chemotherapy when they are pregnant have healthy babies. You can usually start chemotherapy after you are 14 weeks pregnant.
On this page
-
-
About chemotherapy during pregnancy
-
Effects of chemotherapy on the baby
-
When chemotherapy is given during pregnancy
-
Different cancers and chemotherapy
-
Breast cancer and chemotherapy in pregnancy
-
Cancer of the cervix and chemotherapy in pregnancy
-
Non-Hodgkin lymphoma (NHL) and chemotherapy in pregnancy
-
Hodgkin lymphoma (HL) and chemotherapy in pregnancy
-
Acute leukaemia and chemotherapy in pregnancy
-
Getting support
-
How we can help
About chemotherapy during pregnancy
Chemotherapy is the most common treatment used during pregnancy. The drugs destroy cancer cells, but they also affect healthy cells. It is natural to feel anxious about the possible effects of chemotherapy on the baby. But, at the same time, you may want to start treatment for the cancer.
If your doctors think you need chemotherapy, they may:
- delay chemotherapy until after the first trimester
- avoid using a certain drug because it is harmful to the baby
- avoid using a certain drug because there is not enough evidence to show it is safe in pregnancy.
Effects of chemotherapy on the baby
Studies have looked at babies whose mothers had chemotherapy after the first trimester. These studies are generally reassuring. Most women had healthy babies. So far, studies do not show any differences in the baby’s development. But doctors are still studying the long-term effects to find out more about any other possible risks.
Risk of earlier delivery
There is some evidence to suggest chemotherapy may increase the risk of giving birth earlier and the baby having a lower birth weight. But doctors now have more experience giving chemotherapy during pregnancy. This means babies are less likely to be born early. If possible, your doctor will try to help your pregnancy go to full term (37 weeks).
Some women have a higher risk of early delivery. In this situation, doctors recommend they are cared for in hospitals with specialist baby units. These are called obstetric high dependency units (OHDUs).
When chemotherapy is given during pregnancy
You do not usually have chemotherapy during the first trimester. This is because the baby’s organs are still forming, and chemotherapy can increase the risk of a miscarriage or birth defect.
You can usually start chemotherapy after you are 14 weeks pregnant (in the second trimester). At this stage, research shows most chemotherapy drugs will not harm the baby. The placenta acts as a barrier between you and the baby. Some drugs cannot pass through the placenta. Others only pass through in very small amounts. Your cancer doctor and specialist nurse will explain this to you.
Having chemotherapy
You will usually have chemotherapy as an injection or a drip (infusion) into a vein, or as tablets. This is the same for someone who is not pregnant.
It may be helpful to talk to someone who has also had chemotherapy during pregnancy. Mummy’s Star may be able to arrange this for you. Your cancer team may also help with this.
When you stop chemotherapy
Your doctors will talk to you about when you will stop chemotherapy. Chemotherapy is not usually given after you are 37 weeks pregnant. You will have a break between your last dose of chemotherapy and your expected delivery date. This is to avoid the baby being born when your blood cell levels are still low. Having a low level of blood cells is a temporary side effect of chemotherapy. It can increase your risk of serious infection and bleeding.
If your baby is born soon after your chemotherapy finishes, doctors can give you drugs to support your immune system. This helps you fight infections.
Different cancers and chemotherapy
Chemotherapy can be given to treat different cancers during pregnancy. These are some examples. Your specialist doctor or nurse will give you information about your individual situation.
Breast cancer and chemotherapy in pregnancy
You may have chemotherapy before or after surgery to remove breast cancer. Doctors will use the same chemotherapy drugs they would give to someone with breast cancer who is not pregnant.
Your doctor will usually give you a combination of:
- doxorubicin (Adriamycin®)
- cyclophosphamide
- epirubicin.
These drugs used to treat breast cancer during pregnancy.
You might have a drug called docetaxel (Taxotere®) or paclitaxol (Taxol®). These are called taxanes. These drugs are less commonly used in pregnancy. You may have them nearer the end of your chemotherapy treatment. This often means you have them after the baby is born.
You might have other treatments after the baby is born. These include radiotherapy, hormonal and targeted therapy.
Cancer of the cervix and chemotherapy in pregnancy
Doctors will use the same chemotherapy drugs they would give to someone with cervical cancer who is not pregnant.
They may use the drugs cisplatin or carboplatin along with other chemotherapy drugs.
In some situations, chemotherapy may be given so that surgery can be delayed until the baby has grown enough to be born. You may have further treatment, such as surgery or radiotherapy, after the baby is born. You may also have more chemotherapy after the baby is born.
Non-Hodgkin lymphoma (NHL) and chemotherapy in pregnancy
Chemotherapy can be used to treat fast-growing non-Hodgkin lymphoma (NHL) during pregnancy. CHOP is the standard combination of chemotherapy drugs used. It can be given during pregnancy. It is made up of:
- C – cyclophosphamide
- H – doxorubicin (hydroxydaunomycin)
- O – vincristine (Oncovin®)
- P – prednisolone (a steroid).
Rituximab is a targeted therapy drug usually given with CHOP. This treatment is called R-CHOP. Doctors usually give it to you after the baby is born.
Hodgkin lymphoma (HL) and chemotherapy in pregnancy
Hodgkin lymphoma (HL) is commonly treated using a combination of drugs called ABVD. It can be given during pregnancy. It is made up of:
- A – doxorubicin (Adriamycin®)
- B – bleomycin
- V – vinblastine (Velbe®)
- D – dacarbazine (DTIC).
Acute leukaemia and chemotherapy in pregnancy
Chemotherapy is used to destroy all the cancer cells for acute myeloid leukaemia (AML). This is called induction chemotherapy. The drugs that are usually given in this treatment are daunorubicin and cytarabine. You can still have these drugs if you are pregnant.
Acute promyelocytic leukaemia (APL)
A rare type of AML called acute promyelocytic leukaemia (APL) is treated in a different way. The first treatment is a drug called ATRA, which is also called tretinoin or Vesanoid®. ATRA can reduce leukaemia symptoms very quickly. It is usually given with chemotherapy or a drug called arsenic trioxide. You cannot have ATRA during the first 14 weeks of pregnancy.
APL needs to be treated very quickly. There is a risk of having a serious bleed without treatment. Unless it is diagnosed later in pregnancy, doctors may recommend ending the pregnancy. This is so you can have the most effective treatment. If you decide to continue with the pregnancy, ATRA is usually given on its own.
Getting support
Macmillan is here to support you. If you would like to talk, you can:
- Call the Macmillan Support Line for free on 0808 808 00 00.
- Chat to our specialists online.
- Visit our chemotherapy forum to talk with people who have had chemotherapy, share your experience, and ask questions.
About our information
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.
-
References
Below is a sample of the sources used in our pregnancy and cancer information. If you would like more information about the sources we use, please contact us at informationproductionteam@macmillan.org.uk
de Haan J, Verheecke M, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncology. 2018. Vol 19 [accessed October 2023]
Public Health England, Cancer before, during and after pregnancy, National Cancer Registration and Analysis Service 2018 [accessed October 2023]
Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, Van Loon K. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020 Sep;16(9):545-557. doi: 10.1200/OP.20.00077. PMID: 32910882. [accessed September 2023]
Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in cancer Int J Gynecol Cancer 2021;31:314–322.
Reviewer
Consultant Medical Oncologist & Honorary Associate Professor
Date reviewed

Our cancer information meets the PIF TICK quality mark.
This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We want our information to be as clear as possible. To do this, we try to:
- use plain English
- explain medical words
- use short sentences
- use illustrations to explain text
- structure the information clearly
- make sure important points are clear.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.
You can read more about how we produce our information here.
